According to a new study by ReportBuyer, the global infusion pump market was estimated to be worth $8.1 billion in 2016 and is expected to surge to more than $14.7 billion by 2025. The rise in the geriatric population, along with the increased prevalence of chronic diseases, is expected to boost demand for infusion pumps and drive the global market toward rapid growth.
Read More
The U.S. FDA has permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy. In fact, the product, called IDx-DR, is the first device authorized for marketing that provides a screening decision without the need for a clinician to also interpret the image or results.
Read More
The U.S. FDA has permitted marketing of the Dexcom G6 integrated continuous glucose monitoring (iCGM) system for determining blood glucose levels in those ages 2 and older. This enables developers of future iCGM systems to bring their products to market in the least burdensome manner possible, FDA officials say.
Read More
Indiana-based VoCare, Inc. has developed a professional-grade medical diagnostic device that collects six different health vitals and is equipped with WiFi, Bluetooth, and 4G LTE for data transmission, without the need for separate peripherals or an external hub.
Read More
The global connected medical devices market is expected to grow at a compound annual growth rate of 9.24% from 2017 to 2021, according to a new report from market research firm Research and Markets. According to the analysis, the rising prevalence of chronic diseases is a major driver of market growth.
Read More